Future research in ITP: an ICIS consensus
Research output: Contribution to journal › Article
While much has been learned about the basic immunology and clinical characteristics of immune thrombocytopenia, many important questions remain with regard to pathogenesis, disease progression, identification of novel therapeutic targets and approaches, and clinical trials that rationalize and optimize use of existing therapies. The answers to these questions are likely to impact our understanding of the pathogenesis and therapeutic targets of autoimmune disease in general.
|Research areas and keywords||
|Number of pages||5|
|Journal||Annals of Hematology|
|Issue number||Suppl 1|
|Publication status||Published - 2010 Jul|